Cogent Biosciences, Inc. COGT
- bezuclastinib — Non-Advanced Systemic Mastocytosis NDA Submitted
- bezuclastinib — Gastrointestinal Stromal Tumor NDA Submitted
KIT exon 17 (1 companies · 2 programs)
Companies with an active program directed at KIT exon 17.